Longitudinal urine drug testing among patients receiving opioids for cancer pain.

Context: To assess for non-prescribed substance use and adherence to controlled medication treatment, urine drug tests (UDT) are recommended for patients receiving opioids for cancer-related pain management. However, the optimal frequency of UDTs during opioid treatment is unclear.

Objectives: To describe initial and subsequent UDT results among patients diagnosed with cancer receiving outpatient palliative care (PC) at a tertiary cancer center.

Cost Trends of New-To-Market Neurologic Medications: An Insurance Claims Database Analysis.

Background And Objectives: Costs for neurologic medications have increased considerably in recent years. Since 2014, more than 30 neurologic medications have been approved by the US Food and Drug Administration (FDA) for neurologic conditions. This study aims to characterize recent trends in annual costs and aggregate spending from 2012 to 2021 for new-to-market (NTM) medications for 9 neurologic conditions.